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When 8-bromoguanosine was incubated with cysteine at pH 7.4 and 37 C, a previously unidentiﬁed
product was formed as a major product in addition to guanosine. The product was identiﬁed as a cysteine
substitution derivative of guanosine at the 8 position, 8-S-L-cysteinylguanosine. The reaction was accel-
erated under mildly basic conditions. The cysteine adduct of guanosine was fairly stable and decomposed
with a half-life of 193 h at pH 7.4 and 37 C. Similar results were observed for incubation of 8-bromo-20-
deoxyguanosine with cysteine. The results suggest that 8-bromoguanine in nucleosides, nucleotides,
RNA, and DNA can react with thiols resulting in stable adducts.
 2013 The Authors. Published by Elsevier Ltd. Open access under CC BY-NC-ND license.Eosinophil peroxidase (EPO) plays an important role in defense
mechanisms against parasites mediated by the oxidation of Br.1
EPO generates a reactive species hypobromous acid (HOBr) from
H2O2 and Br. An EPO/H2O2/Br system in the presence of a plasma
concentration of Cl can react with nucleosides to form
brominated nucleosides including 8-bromo-20-deoxyguanosine
(8-Br-dGuo).2–4 Meanwhile, myeloperoxidase (MPO), an enzyme
secreted from neutrophil and monocytic cells, generates hypochlo-
rous acid (HOCl) from H2O2 and Cl.5,6 The formed HOCl is also of
central importance in host defense mechanisms. MPO can generate
chlorinated nucleosides including 8-chloro-20-deoxyguanosine (8-
Cl-dGuo).7 It has been reported that an MPO/H2O2/Cl system in
the presence of a plasma concentration of Br also generates bro-
minated nucleosides.8 HOCl formed in the MPO system would re-
act with Br, generating a brominating reagent, HOBr. An in vitro
DNA replication study showed that human DNA polymerases
incorporated 20-deoxyguanosine-50-monophosphate (dGMP), 20-
deoxyadenosine-50-monophosphate (dAMP), and 20-deoxythymi-
dine-50-monophosphate (dTMP) in addition to one-base deletion
opposite to an 8-Br-dGuo residue in an oligodeoxynucleotide, sug-
gesting that 8-Br-dGuo in DNA is a mutagenic lesion.9 Recently,
8-Br-dGuo was detected in urine from healthy volunteers with a
similar concentration of 8-Cl-dGuo, while the concentrations areone order of magnitude lower than that of 8-oxo-7,8-dihydroxy-
20-deoxyguanosine (8-oxo-dGuo).10 In diabetic patients, urinary
8-Br-dGuo and 8-Cl-dGuo levels were eightfold higher than the
levels in healthy volunteers, whereas there was a small increase
in 8-oxo-dGuo. This implies that 8-Br-dGuo exists in healthy hu-
mans and that inﬂammatory diseases greatly increase its level.
Thus, the importance of 8-Br-dGuo is becoming clear. However,
there is little information available about the reaction of 8-Br-dGuo
with intracellular molecules. In the present study, we investigated
the reaction of 8-bromoguanosine (8-Br-Guo) with L-cysteine (Cys)
and report identiﬁcation of the products.
A solution of 100 lM 8-Br-Guo (Santa Cruz Biotechnology, TX,
USA) and 50 mM Cys (Sigma, MO, USA) was incubated in
100 mM potassium phosphate buffer at pH 7.4 and 37 C for 48 h
in the dark. When the reaction mixture was analyzed by reversed
phase (RP) HPLC, two product peaks appeared in the chromato-
gram (Fig. 1). The products were collected and subjected to spec-
trometric measurements. The product eluted at the retention
time of 6.5 min showed a UV spectrum with kmax = 252 nm and
an ESI-TOF/MS spectrum with m/z = 282 in the negative mode.
The product was identiﬁed as guanosine (Guo) by coincidence of
the RP-HPLC retention time and UV and MS spectra of an authentic
Guo. The product eluted at the retention time of 7.7 min showed a
UV spectrum with kmax = 272 nm (Fig. 1, inset). An ESI-TOF/MS
spectrum showed m/z = 401 and 314 in the negative mode
(Fig. 2). High-resolution ESI-TOF/MS (negative) of the molecular
ion showed m/z = 401.088576, which agreed with the theoretical
molecular mass for C13H17N6O7S composition within 1 ppm. 1H-
NMR showed no aromatic proton signal and three aliphatic proton
signals in addition to six aliphatic ribose proton signals. 13C-NMR
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Figure 1. RP-HPLC chromatogram of a reaction mixture of 8-Br-Guo with Cys
detected at 260 nm. The inset is the on-line UV spectrum of Cys-Guo. A solution of
100 lM 8-Br-Guo and 50 mM Cys was incubated in 100 mM potassium phosphate
buffer at pH 7.4 and 37 C for 48 h in the dark. The HPLC system consisted of
Shimadzu LC-10ADvp pumps and an SCL-10Avp system controller. On-line UV
spectra were obtained with a Shimadzu SPD-M10Avp UV–vis photodiode-array
detector. For the RP-HPLC, an Inertsil ODS-3 octadecylsilane column of
4.6  250 mm and particle size 5 lm (GL Science, Tokyo) was used. The eluent
was 20 mM ammonium acetate (pH 7.0) containing 10% methanol. The column
temperature was 40 C and the ﬂow rate was 1 mL/min.
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Figure 2. Negative ion electrospray ionization time of ﬂight mass spectrometry
(ESI-TOF/MS, MicroTOF, Bruker) spectrum of 8-S-L-cysteinylguanosine (Cys-Guo).
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Figure 4. (A) The time course of the concentration changes in 8-Br-Guo (circle),
Cys-Guo (square), and Guo (triangle) when a solution of 100 lM 8-Br-Guo and
50 mM Cys was incubated in 100 mM potassium phosphate buffer at pH 7.4 and
37 C for 0–96 h in the dark. (B) The Cys dose dependence of the concentration
changes in 8-Br-Guo (circle), Cys-Guo (square), and Guo (triangle) when a solution
of 100 lM 8-Br-Guo and 0–100 mM Cys was incubated in 100 mM potassium
phosphate buffer at pH 7.4 and 37 C for 48 h in the dark. The concentration was
determined by RP-HPLC. Means ± S.D. (n = 3) are presented.
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Figure 5. The pH dependence of the concentration changes in 8-Br-Guo (circle),
Cys-Guo (square), and Guo (triangle) when a solution of 100 lM 8-Br-Guo and
50 mM Cys was incubated in 100 mM potassium phosphate buffer at pH 3–11 and
37 C for 48 h in the dark. The concentration was determined by RP-HPLC.
Means ± S.D. (n = 3) are presented.
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signals with a carboxyl carbon signal (171.0 ppm). Combining
these data, the product was identiﬁed as a Cys-substituted deriva-
tive of Guo at the 8 position, (Cys-Guo).11 The structures of the
products are shown in Figure 3. Concentrations of the products
were 15.6 ± 0.2 lM for Cys-Guo and 8.9 ± 0.2 lM for Guo with
74.3 ± 0.6 lM of unreacted 8-Br-Guo.12 As a control, a similar
experiment was conducted for glycine (Gly). Incubation of a solu-
tion of 100 lM 8-Br-Guo with 50 mM Gly at pH 7.4 and 37 C for
up to 120 h showed no product and no consumption of 8-Br-Guo.
Figure 4A shows the time-dependent changes in concentrations
of Cys-Guo, Guo, and 8-Br-Guo, when 100 lM 8-Br-Guo and
50 mM Cys were incubated in 100 mM potassium phosphate buffer
at pH 7.4 and 37 C for 0–96 h. The concentrations of Cys-Guo and
Guo increased with increasing incubation time. Cys-Guo formed
with a higher concentration than Guo. Figure 4B shows the Cys
dose-dependence of concentrations of the products and 8-Br-
Guo, when 100 lM 8-Br-Guo and 0–100 mM Cys were incubated
in 100 mM potassium phosphate buffer at pH 7.4 and 37 C forNH
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Figure 3. Reaction of 8-Br-Guo with Cys. R denotes ribose.48 h. The concentrations of the products increased with increasing
Cys dose.
Figure 5 shows the pH dependence of the concentrations of the
products and 8-Br-Guo. Consumption of 8-Br-Guo increased with
increasing pH value of the solution from pH 7 to pH 8. The concen-
tration of Cys-Guo increased with increasing pH from 7 to 8. How-
ever, the concentration of Guo gradually decreased as the pH
increased.
Figure 6 shows the stability of Cys-Guo. 100 lM Cys-Guo was
incubated in 100 mM potassium phosphate buffer of pH 3.0, 7.4,40
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Figure 6. The time course of the concentration changes in Cys-Guo at pH 3.0
(circle), pH 7.4 (triangle), and pH 8.5 (square) when a solution of isolated 100 lM
Cys-Guo was incubated in 100 mM potassium phosphate buffer at pH 3.0, 7.4, or 8.5
and 37 C for up to 96 h in the dark. The concentration was determined by RP-HPLC.
Means ± S.D. (n = 3) are presented.
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Scheme 1. Proposed reaction pathways for the reaction of 8-Br-Guo with Cys.
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Guo did not change. At pH 7.4, Cys-Guo decreased time-depen-
dently with a half-life of 193 h. Although several products were de-
tected in the RP-HPLC chromatogram, Guo did not form. At pH 8.5,
the half-life was 244 h. As a control, 8-Br-Guo was incubated under
the same conditions, but no decomposition was observed.
To obtain information about the reaction of an 8-bromoguanine
moiety in deoxyribonucleoside with Cys, similar experiments were
conducted for 8-bromo-20-deoxyguanosine (8-Br-dGuo). When a
solution of 100 lM 8-Br-dGuo (Santa Cruz Biotechnology) and
50 mM Cys was incubated in 100 mM potassium phosphate buffer
at pH 7.4 and 37 C in the dark, 8-S-L-cysteinyl-20-deoxyguanosine
(Cys-dGuo)13 and dGuo were generated. At an incubation time of
48 h, the concentrations of the products were 20.1 ± 1.3 lM for
Cys-dGuo and 9.5 ± 0.7 lM for dGuo with 66.2 ± 2.0 lM of unre-
acted 8-Br-dGuo.14
To obtain information about the reaction mechanism generat-
ing Guo, two experiments were conducted. 100 lM Cys-Guo was
incubated with 50 mM Cys in 100 mM potassium phosphate buffer
(pH 7.4) at 37 C for up to 72 h and the reaction mixture was ana-
lyzed by RP-HPLC. The concentration of Cys-Guo decreased, but
Guo did not form. It suggests that Cys does not catalyze the forma-
tion of Guo from Cys-Guo. 100 lM 8-Br-Guo was incubated with
50 mM NaBH4, a reducing agent, in 100 mM potassium phosphate
buffer (pH 7.4) at room temperature for 1 h. However, the concen-
tration of 8-Br-Guo did not decrease and Guo was not detected in
the RP-HPLC chromatogram.
It has been reported that 5-bromo-20-deoxyuridine (5-Br-dUrd)
reacts with Cys generating a Cys adduct, 5-S-L-cysteinyl-20-deoxy-
uridine (Cys-dUrd), and a debromination product, 20-deoxyuridine
(dUrd).15 The dUrd formation in the 5-Br-dUrd/Cys reaction was
maximal at pH 8, and the Cys-dUrd formation was most favorable
at pH 9. The reaction was very slow below pH 5 and above pH 10.
The pH proﬁle for the product yields is quite different from that of
the present 8-Br-Guo/Cys reaction, suggesting that a different reac-
tion mechanism exists. In the reaction of 8-Br-Guo with Cys, the
yield of Cys-Guo increased with increasing pH with a sigmoidal
proﬁle (Fig. 4). The pKa of Cys is 8.3 for the thiol group.16 At mildly
acidic pH, a simple nucleophilic attack of the thiol group (–SH) of
Cys to C8 of 8-Br-Guo and subsequent elimination of Br and H+
would generate Cys-Guo. The thiolate (–S) of Cys formed at mildly
basic pH attacks the C8 atom more efﬁciently. In contrast, the yield
of Guo gradually decreased with increasing pH. For the formation
of Guo, the pathway via Cys-Guo was ruled out. Meanwhile, Guo
was not generated from 8-Br-Guo by NaBH4. The reaction mecha-
nism for the formation of Guo from 8-Br-Guo by Cys is unclear.
The possible reaction pathways are summarized in Scheme 1.Cys-Guo was relatively stable (Fig. 5). If Cys adducts at guanine
C8 were formed in RNA and DNA, they would remain for a long
period. Although the serum concentration of Cys is low (34 lM),
the intracellular level of glutathione (GSH, pKa = 8.8) in mamma-
lian cells is in the millimolar range (0.5–10 mM).17,18 GSH may also
react with 8-bromoguanine, generating stable products as well as
free Cys at guanine C8 in RNA and DNA. These thiol adducts at
C8 of guanine can exert an inﬂuence on RNA and DNA functions
different from that of 8-bromoguanine. Recently, a new signal
transduction mechanism termed protein S-guanylation was re-
vealed.19 8-Nitroguanosine-30,50-cyclic monophosphate (8-NO2-
cGMP) reacts with cysteine thiols of a protein Keap1, generating
cGMP adduct of the protein. The formation of S-guanylation regu-
lated the redox-sensor signaling protein. The results of the present
study suggest that 8-bromoguanosine-30,50-cyclic monophosphate
(8-Br-cGMP), either generated by endogenously-formed HOBr
from guanosine-30,50-cyclic monophosphate (cGMP) or added
exogenously as a reagent, may also react partially with cysteine
thiols of proteins resulting in cGMP adducts as well as 8-NO2-
cGMP. The reaction of 8-bromoguanine nucleosides with Cys may
be slower than that of 8-nitroguanine nucleosides with Cys. How-
ever, 8-bromoguanine nucleosides are relatively stable, whereas 8-
nitroguanine nucleosides are labile for N-glycosidic bond, resulting
in depurination, with half-lives of 3 min for 8-nitro-20-deoxygua-
nosine and 5 h for 8-nitroguanosine at pH 7 and 37 C.20,21 Thus,
8-bromoguanine would stay in nucleosides and nucleic acids for
a long period and can react with thiols resulting in adducts.
The present results show that relatively stable Cys adducts can
form from 8-bromoguanine nucleosides under neutral conditions.
It suggests that these adducts may have some importance in eluci-
dating the inﬂuence of 8-bromoguanine in nucleosides, nucleo-
tides, RNA and DNA in genotoxicity and signal transduction.
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